Celiac Disease Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
SKU : PH2750
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Celiac Disease Drugs Market?
Celiac Disease Drugs Market is expected to grow at a CAGR of 8.28% during the forecast period 2024-2031
Who are the key players in Celiac Disease Drugs Market?
Major players are Innovate Biopharmaceuticals, Teva Pharmaceutical Industries Ltd, ImmunogenX, LLC, Amgen, ChemoCentryx, Inc, Anokion SA, COUR Pharmaceutical, F. Hoffmann-La Roche Ltd, ImmusanT, Inc, BioLineRx Ltd, and Takeda Pharmaceutical Company Limited, among others.
Related Reports
pharmaceuticalsViral Vector Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsInterferon Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsAndrogenetic Alopecia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 25
Starting from
$4350
pharmaceuticalsNon-oncology Biopharmaceuticals Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 06
Starting from
$3750
pharmaceuticalsParathyroid Hormone Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 07
Starting from
$4350
pharmaceuticalsIntegrin Beta 3 Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 06
Starting from
$4350